Michael Williamson

2.3k total citations
6 papers, 161 citations indexed

About

Michael Williamson is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Michael Williamson has authored 6 papers receiving a total of 161 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Epidemiology and 1 paper in Surgery. Recurrent topics in Michael Williamson's work include Cystic Fibrosis Research Advances (4 papers), Neonatal Respiratory Health Research (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Michael Williamson is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Neonatal Respiratory Health Research (4 papers) and Inhalation and Respiratory Drug Delivery (2 papers). Michael Williamson collaborates with scholars based in Ireland, United States and Brazil. Michael Williamson's co-authors include Peter Greally, Emer P. Reeves, Noel G. McElvaney, Shane O’Neill, Christine M. Lovly, Leora Horn, Ibiayi Dagogo‐Jack, Adrienne Johnson, Siraj M. Ali and Vincent A. Miller and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Archives of Disease in Childhood.

In The Last Decade

Michael Williamson

4 papers receiving 159 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Williamson Ireland	4	110	38	35	28	19	6	161
Gee-Chen Chang Taiwan	6	112 1.0×	32 0.8×	60 1.7×	15 0.5×	10 0.5×	12	180
Yang Dongliang China	7	43 0.4×	72 1.9×	24 0.7×	50 1.8×	18 0.9×	11	157
Stephan Spahn Germany	6	59 0.5×	47 1.2×	57 1.6×	14 0.5×	12 0.6×	15	160
Juliana Machado‐Rugolo Brazil	8	45 0.4×	35 0.9×	64 1.8×	20 0.7×	22 1.2×	29	123
Neil Mundi United States	10	35 0.3×	73 1.9×	66 1.9×	44 1.6×	13 0.7×	33	211
Kei Daizumoto Japan	8	79 0.7×	63 1.7×	38 1.1×	37 1.3×	20 1.1×	39	195
Fuai Lu China	5	97 0.9×	74 1.9×	8 0.2×	20 0.7×	24 1.3×	6	172
Daisuke Douchi Japan	8	96 0.9×	73 1.9×	78 2.2×	27 1.0×	22 1.2×	20	210
John Ryan Thompson United States	7	77 0.7×	49 1.3×	10 0.3×	8 0.3×	15 0.8×	8	167

Countries citing papers authored by Michael Williamson

Since Specialization

Citations

This map shows the geographic impact of Michael Williamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Williamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Williamson more than expected).

Fields of papers citing papers by Michael Williamson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Williamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Williamson. The network helps show where Michael Williamson may publish in the future.

Co-authorship network of co-authors of Michael Williamson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Williamson. A scholar is included among the top collaborators of Michael Williamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Williamson. Michael Williamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Gogoi, Debananda, Claudie Gabillard-Lefort, Sarfraz Ahmed, et al.. (2025). CFTR modulator therapy impacts neutrophil CD39 expression in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology. 74(3). 403–406.

2.

Ryan, Stephanie, et al.. (2019). P051 The bigger you are the harder you fall? Short term effects of LUM/IVA (Orkambi) on lung function in children with cystic fibrosis. Archives of Disease in Childhood. 104(7). e2.57–e2.

3.

Ou, Sai‐Hong Ignatius, Leora Horn, Christine M. Lovly, et al.. (2017). Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients. Lung Cancer. 111. 61–64. 47 indexed citations

4.

Levy, Yadin D., Michael Williamson, Cesar Flores‐Hernandez, Darryl D. DʼLima, & Heinz R. Hoenecke. (2014). Glenoid Rim Anatomy. Orthopaedic Journal of Sports Medicine. 2(11). 1805603681–1805603681. 5 indexed citations

5.

Reeves, Emer P., Michael Williamson, Shane O’Neill, Peter Greally, & Noel G. McElvaney. (2011). Nebulized Hypertonic Saline Decreases IL-8 in Sputum of Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 183(11). 1517–1523. 70 indexed citations

6.

Reeves, Emer P., Michael Williamson, Barry J. Byrne, et al.. (2009). IL-8 Dictates Glycosaminoglycan Binding and Stability of IL-18 in Cystic Fibrosis. The Journal of Immunology. 184(3). 1642–1652. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact